Tarsons Products Ltd
Pharmaceuticals & Biotechnology | Small Cap
Tarsons Products Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strong solvency and profitability, indicating a solid foundation. However, its liquidity and efficiency ratios reveal areas needing attention. While revenue growth is positive, declines in operating profit, EPS, asset growth, and net income raise concerns about sustainable growth. The company's interest coverage is strong, but its dividend coverage is weak. Overall, Tarsons shows promising profitability but faces challenges in efficiency and consistent growth. The healthcare industry's specific dynamics, such as regulatory changes and market competition, may influence these financial metrics. The company's future performance will depend on addressing these challenges and capitalizing on its strengths.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio4.00
- Financial Ratio6.00
- Profitability Ratio10.00
- Efficiency Ratio3.00
- Coverage Ratio6.80
- Solvency Ratio9.50
- Liquidity Ratio6.68
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursBullish
- 1 DayBullish
- 1 WeekNeutral
- 1 MonthNeutral
Tarsons Products Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strong solvency and profitability, indicating a solid foundation. However, its liquidity and efficiency ratios reveal areas needing attention. While revenue growth is positive, declines in operating profit, EPS, asset growth, and net income raise concerns about sustainable growth. The company's interest coverage is strong, but its dividend coverage is weak. Overall, Tarsons shows promising profitability but faces challenges in efficiency and consistent growth. The healthcare industry's specific dynamics, such as regulatory changes and market competition, may influence these financial metrics. The company's future performance will depend on addressing these challenges and capitalizing on its strengths.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
Overall Valuation Score
P/E RATIO (TTM)
62.75
Industry Median
59.78
Small Cap Median
59.78
P/E RATIO
99.38
P/B RATIO
2.25
Industry Median
2.25
Small Cap Median
2.25
P/S RATIO
3.36
Industry Median
3.36
Small Cap Median
3.36
Others
PEG RATIO
-3.02
EV/EBITDA RATIO
11.39
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹267.32 as on Jun 18, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Quarterly Report⬤6th Feb 26
Quarterly Financial Results Q3 FY 2025-26
NEUTRAL SENTIMENT
Tarsons Products Ltd. shows a mixed growth performance. While the Revenue Growth Rate is positive, indicating increasing sales, the declines in Operating Profit Growth Rate, Earnings Per Share (EPS) Growth, Asset Growth Rate, and Net Income Growth Rate raise concerns about sustainability. The weighted average calculation offers a balanced view of these trends, emphasizing the need for improvements in profitability and operational efficiency to support future growth.
| Growth Ratios | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 31.44 | 32.43 | 7.91 | ||
| Operating Profit Growth Rate | 48.54 | 11 | 6.31 | ||
| Earnings Per Share (EPS) Growth | -99.47 | -30.09 | -51.96 | ||
| Asset Growth Rate | 83.78 | 11.11 | 9.81 | ||
| Net Income Growth Rate | 46.38 | -30.23 | -53.33 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Tarsons Products Ltd.'s financial ratios offer a mix of strengths and weaknesses. Adjusted Earnings Per Share (Adjusted EPS) and Cash Earnings Per Share (Cash EPS) indicate good profitability. The Book Value Per Share shows a solid equity base. However, the Dividend Per Share (DPS) is low, and Capital Expenditures (CapEx) are relatively high. The weighted average calculation provides a comprehensive view, emphasizing the need to balance profitability with strategic investments and shareholder returns.
| Financial Ratios | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 689.2 | 18.36 | 7.83 | 5.41 | 2.68 |
| Cash Earnings Per Share (Cash EPS) | 830 | 22.36 | 15.09 | 16.73 | 20.18 |
| Book Value Per Share | 2441.9 | 89.09 | 111.45 | 114.73 | 115.45 |
| Dividend Per Share (DPS) | 0 | 0 | 2 | 0 | 0 |
| Capital Expenditures (CapEx) | 62 | 132 | 184 | 151 | 126 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
Tarsons Products Ltd. exhibits strong profitability, with high Gross Profit Margin, Return on Capital Employed (ROCE), Return on Equity (ROE), Return on Assets (ROA), Operating Margin, and Net Margin. These metrics indicate efficient operations and effective use of capital. The weighted average calculation confirms these trends, highlighting the company's ability to generate profits consistently. This strong profitability positions the company well within the Healthcare Services sector.
| Profitability Ratios | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 38.86 | 43.52 | 20.27 | 12.5 | 4.96 |
| Return on Capital Employed (ROCE) | 34.27 | 35 | 9.77 | 7 | 5 |
| Return on Equity (ROE) | 28.26 | 20.61 | 7.01 | 4.75 | 2.2 |
| Return on Assets (ROA) | 34.8 | 28.12 | 10.29 | 10.28 | 9.95 |
| Operating Margin | 44.98 | 50.83 | 33.78 | 28.32 | 27.9 |
| Net Margin | 30.13 | 33.55 | 14.53 | 7.65 | 3.31 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
Tarsons Products Ltd.'s efficiency ratios suggest areas of concern. The Fixed Asset Turnover Ratio and Capital Turnover Ratio indicate that the company is not generating substantial revenue from its fixed assets or capital. The Inventory Turnover Ratio and Days Sales in Inventory Ratio point to some difficulties in managing inventory effectively. The Receivables Turnover Ratio and Receivable Days also suggest challenges in collecting receivables promptly. The weighted average calculation emphasizes the need for improvements in asset utilization and working capital management to boost overall efficiency.
| Efficiency Ratios | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 1.91 | 1.59 | 0.88 | 0.73 | 0.58 |
| Inventory Turnover Ratio | 2.96 | 2.64 | 1.83 | 2.7 | 3.14 |
| Receivables Turnover Ratio | 4.87 | 5.38 | 3.8 | 4.96 | 5.13 |
| Days Sales in Inventory Ratio | 123.31 | 138.26 | 199.45 | 135.19 | 116.24 |
| Receivable Days | 75 | 67.84 | 96 | 73.59 | 71.15 |
| Capital Turnover Ratio | 0.83 | 0.59 | 0.41 | 0.46 | 0.49 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
Tarsons Products Ltd.'s coverage ratios present a mixed picture. The Interest Coverage Ratio indicates a strong ability to cover interest expenses, suggesting healthy financial management. However, the Equity Dividend Coverage Ratio is low, indicating a limited capacity to cover dividend payments with available equity. The weighted average calculation considers these factors, highlighting the need for a balanced approach to capital allocation.
| Coverage Ratios | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 31.67 | 34.75 | 7.1 | 3.25 | 1.96 |
| Equity Dividend Coverage Ratio | 4 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
Tarsons Products Ltd. demonstrates robust solvency. The Debt Ratio and Debt to Equity Ratio indicate low levels of debt relative to assets and equity, respectively. The Equity Ratio shows a strong proportion of equity in the company's capital structure. The Debt To Asset Ratio confirms that a small portion of assets is financed through debt. The weighted average calculation provides a comprehensive view of the company's long-term financial stability.
| Solvency Ratios | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.12 | 0.04 | 0.16 | 0.26 | 0.26 |
| Debt to Equity Ratio | 0.14 | 0.04 | 0.19 | 0.35 | 0.35 |
| Equity Ratio | 0.88 | 0.96 | 0.84 | 0.74 | 0.74 |
| Debt To Asset Ratio | 0.11 | 0.04 | 0.12 | 0.2 | 0.19 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
Tarsons Products Ltd.'s liquidity position reflects a mix of strengths and weaknesses. While the Quick Ratio indicates a reasonable ability to meet short-term obligations without relying on inventory, the Current Ratio suggests some difficulties in covering immediate liabilities. The Cash Ratio shows a modest level of readily available cash relative to current liabilities. The Operating Cash Flow Ratio indicates the company's ability to generate cash from its operations to cover current liabilities. The weighted average calculation highlights these nuances, suggesting there's a need for enhanced short-term financial management.
| Liquidity Ratios | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 8.5 | 9.79 | 1.51 | 1.32 | 0.89 |
| Quick Ratio | 5.89 | 7.3 | 0.98 | 0.79 | 0.5 |
| Cash Ratio | 0.17 | 2.61 | 0.09 | 0.11 | 0.08 |
| Operating Cash Flow Ratio | 3.78 | 2.52 | 0.42 | 0.49 | 0.36 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Aprameya Engineering Ltd | 7.25 | 59.78 | Neutral | 10.53 | 2.65 | 5.13 |
| 2 | Tarsons Products Ltd | 5.90 | 99.38 | Neutral | 118.00 | 4.26 | 14.00 |
The management of Tarsons Products demonstrates strengths in maintaining a consistent promoter holding and achieving sales growth. However, declining profit growth, a decreasing operating profit margin, and increased borrowings indicate significant weaknesses. While sales have grown, profitability has suffered, and the increased debt burden raises concerns about financial risk. This mixed performance warrants an 'Orange' flag, suggesting moderate concern that requires close monitoring.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Sales Growth | 32% | Strong sales growth is evident. |
| Promoter Holding | 47.31% | Consistent promoter holding indicates confidence. | |
| CONS | Profit Growth | -30% | Declining profit growth is a concern. |
| Operating Profit Margin | 28% | Declining OPM indicates operational inefficiency. | |
| Increase in Borrowings | 339 Cr. | Increased borrowings raise concerns about leverage. |
Financial Performance & Growth
Tarsons Products demonstrates a mixed performance in financial growth. Sales growth is robust, but profit growth and operating margins show concerning trends. The compounded sales growth is strong, with TTM at 32%. However, the compounded profit growth is -30% TTM, indicating a significant decline in profitability. Quarterly results show a decrease in OPM from 51-53% in 2020-2022 to 22-33% in recent quarters. This disparity between sales and profit growth raises concerns about cost management and operational efficiency.
| Metric | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Sales Growth (%) | 31.40% | 32.40% | ||
| OPM (%) | 45% | 51% | 34% | 28% |
Capital Efficiency & Returns
The capital efficiency and returns of Tarsons Products show mixed results. ROCE declined to 7% in Mar 2025. The Cash Conversion Cycle has improved from 602 days in Mar 2024 to 385 days in Mar 2025. The ROCE has declined, reflecting less efficient capital use. The improving CCC suggests better working capital management, but the decline in ROCE is a counteracting factor.
| Metric | Mar 2022 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| ROCE (%) | 35% | 7% | |
| Cash Conversion Cycle (Days) | 482 | 602 | 385 |
Financial Health & Prudence
Tarsons Products exhibits concerning trends in financial health. Borrowings have significantly increased, rising from 34 Cr. in Mar 2021 to 339 Cr. in Mar 2025. This increase in debt raises concerns about financial leverage. Interest payments have also increased from 3 Cr. in Mar 2021 to 19 Cr. in Mar 2025, reflecting the higher debt burden. The increased borrowings and interest expenses impact the company's profitability and financial stability.
| Metric | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Borrowings (Cr.) | 34 | 22 | 269 | 339 |
| Interest (Cr.) | 3 | 4 | 10 | 19 |
Shareholding & Ownership Structure
The shareholding structure of Tarsons Products indicates stable promoter confidence, but declining DII interest. Promoter holding remains consistent at 47.31% from June 2022 to March 2025. FII holding increased from 8.16% in Mar 2024 to 9.53% in Mar 2025. DII holding has decreased from 8.06% in Jun 2022 to 0.30% in Mar 2025. The steady promoter holding suggests confidence in the company's prospects, while the shifts in FII and DII holdings reflect changing institutional sentiment.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Promoter Holding (%) | 47.31% | 47.31% | 47.31% | 47.31% |
| FII Holding (%) | 9.12% | 9.16% | 8.16% | 9.53% |
| DII Holding (%) | 7.76% | 8.45% | 0.17% | 0.30% |
Tarsons Products faces a moderate risk profile. The company exhibits segment performance volatility and increasing financial leverage. The decline in operating profit margin and profit growth indicates potential operational inefficiencies and cost management issues. Increased borrowings further heighten financial risk. These factors collectively suggest a need for careful monitoring and strategic adjustments to mitigate risks and ensure sustainable performance.
Segment performance volatility
The quarterly results show fluctuations in sales and profit growth, indicating segment performance volatility. YOY Sales Growth % varied significantly, with a recent increase of 54.85% in Dec 2024, but a lower 6.59% in Mar 2025. YOY Profit Growth % also fluctuated, with a recent decline of -47.03% in Dec 2024 and -1.16% in Mar 2025. These variations indicate potential inconsistencies in segment performance, requiring proactive management to ensure financial stability.
Foreign exchange or interest rate exposure
With increasing borrowings, Tarsons Products is likely exposed to interest rate risk. The rise in interest payments from 3 Cr. in Mar 2021 to 19 Cr. in Mar 2025 suggests a growing sensitivity to interest rate fluctuations. This increased exposure could impact profitability if interest rates rise.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
- IndicatorValueSignal
- SMA 10263.64Bullish
- SMA 20267.43Bearish
- SMA 50235.45Bullish
- EMA 10263.42Bullish
- EMA 20259.84Bullish
- EMA 50243.91Bullish
- DEMA 10264.00Bullish
- DEMA 20270.40Bearish
- DEMA 50263.76Bullish
- TEMA 10261.29Bullish
- TEMA 20266.91Bearish
- TEMA 50274.33Bearish
- MACD6.86Bearish
- ADX42.87Strong Trend
- IndicatorValueSignal
- RSI62.93Neutral
- CCI-48.36Neutral
- ROC 9-1.19Bearish
- ROC 14-3.00Bearish
- ROC 2516.02Bullish
- Stoch K30.59Neutral
- Stoch D21.19Neutral
- IndicatorValueSignal
- BB Upper277.74Neutral
- BB Middle267.43Neutral
- BB Lower257.13Neutral
- ATR5.55Low Volatility
- IndicatorValueSignal
- MFI17.92Oversold
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 10267.16Bearish
- SMA 20249.09Bullish
- SMA 50224.72Bullish
- EMA 10261.53Bullish
- EMA 20251.39Bullish
- EMA 50233.60Bullish
- DEMA 10269.32Bearish
- DEMA 20269.73Bearish
- DEMA 50249.98Bullish
- TEMA 10265.26Bullish
- TEMA 20274.82Bearish
- TEMA 50262.59Bullish
- MACD13.51Bearish
- ADX45.51Strong Trend
- IndicatorValueSignal
- RSI67.50Neutral
- CCI47.13Neutral
- ROC 9-5.39Bearish
- ROC 1412.61Bullish
- ROC 2530.88Bullish
- Stoch K66.90Neutral
- Stoch D69.47Neutral
- IndicatorValueSignal
- BB Upper299.41Neutral
- BB Middle249.09Neutral
- BB Lower198.76Neutral
- ATR7.49Low Volatility
- IndicatorValueSignal
- MFI88.72Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 10249.78Bullish
- SMA 20228.75Bullish
- SMA 50218.57Bullish
- EMA 10251.87Bullish
- EMA 20237.86Bullish
- EMA 50224.00Bullish
- DEMA 10269.47Bearish
- DEMA 20255.89Bullish
- DEMA 50236.15Bullish
- TEMA 10274.09Bearish
- TEMA 20268.07Bearish
- TEMA 50N/AN/A
- MACD15.02Bullish
- ADX31.47Strong Trend
- IndicatorValueSignal
- RSI70.61Overbought
- CCI97.72Neutral
- ROC 927.62Bullish
- ROC 1428.44Bullish
- ROC 2529.58Bullish
- Stoch K76.50Neutral
- Stoch D78.78Neutral
- IndicatorValueSignal
- BB Upper283.68Neutral
- BB Middle228.75Neutral
- BB Lower173.81Neutral
- ATR10.52Low Volatility
- IndicatorValueSignal
- MFI92.60Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 10223.73Bullish
- SMA 20218.02Bullish
- SMA 50214.32Bullish
- SMA 100204.20Bullish
- SMA 200235.03Bullish
- EMA 10232.87Bullish
- EMA 20223.22Bullish
- EMA 50214.88Bullish
- EMA 100216.81Bullish
- EMA 200241.98Bullish
- DEMA 10248.83Bullish
- DEMA 20233.51Bullish
- DEMA 50221.10Bullish
- DEMA 100200.56Bullish
- DEMA 200184.77Bullish
- TEMA 10260.75Bullish
- TEMA 20241.02Bullish
- TEMA 50230.80Bullish
- TEMA 100217.64Bullish
- TEMA 200187.79Bullish
- MACD9.29Bullish
- ADX34.01Strong Trend
- IndicatorValueSignal
- RSI70.60Overbought
- CCI273.07Overbought
- ROC 1427.62Bullish
- ROC 2523.28Bullish
- Stoch K86.31Overbought
- Stoch D65.76Neutral
- IndicatorValueSignal
- BB Upper257.74Overbought
- BB Middle218.02Neutral
- BB Lower178.31Neutral
- ATR14.56High Volatility
- IndicatorValueSignal
- MFI99.16Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 20202.20Bullish
- SMA 50254.79Bearish
- EMA 20212.43Bearish
- EMA 50250.94Bearish
- DEMA 20196.62Bullish
- DEMA 50182.47Bullish
- TEMA 20210.10Bearish
- TEMA 50180.47Bullish
- MACD-9.76Bullish
- ADX24.65Weak Trend
- IndicatorValueSignal
- RSI41.83Neutral
- CCI-58.70Neutral
- ROC 148.33Bullish
- ROC 25-10.83Bearish
- Stoch K47.35Neutral
- Stoch D56.01Neutral
- IndicatorValueSignal
- BB Upper229.50Neutral
- BB Middle202.20Neutral
- BB Lower174.89Neutral
- ATR21.90Low Volatility
- IndicatorValueSignal
- MFI60.77Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 6202.34Bullish
- SMA 12258.91Bearish
- SMA 24331.94Bearish
- EMA 6215.13Bearish
- EMA 12250.55Bearish
- EMA 24320.09Bearish
- DEMA 6189.87Bullish
- DEMA 12183.99Bullish
- DEMA 24193.43Bullish
- TEMA 6199.44Bullish
- TEMA 12181.21Bullish
- TEMA 24N/AN/A
- MACDN/AN/A
- ADX29.67Strong Trend
- IndicatorValueSignal
- RSI37.78Neutral
- CCI-120.74Oversold
- ROC 25-54.39Bearish
- ROC 50-70.20Bearish
- Stoch K14.23Oversold
- Stoch D15.24Oversold
- IndicatorValueSignal
- BB Upper464.44Neutral
- BB Middle302.74Neutral
- BB Lower141.05Neutral
- ATR67.11Low Volatility
- IndicatorValueSignal
- MFI21.52Neutral